Prediction of biomarker signatures and therapeutic agents from blood sample against Pancreatic Ductal Adenocarcinoma (PDAC): A network-based study

Prediction of biomarker signatures and therapeutic agents from blood sample against Pancreatic Ductal Adenocarcinoma (PDAC): A network-based study

Pancreatic Ductal Adenocarcinoma (PDAC) is a form of pancreatic cancer with poor prognosis and rising incidence. Difficulties in the early detection and aggressive biological nature of this disease are responsible for most of the therapeutic failures. In this study, publicly available microarray exp...

Full description

Bibliographic Details
Main Authors: Md Asad Ullah, Bishajit Sarkar, Fayza Akter
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Informatics in Medicine Unlocked
Subjects:
Adenocarcinoma
Biomarkers
Cancer
Pancreatic
PDAC
Treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S2352914820301301

Internet

http://www.sciencedirect.com/science/article/pii/S2352914820301301

Similar Items